Prime Therapeutics Gets Big Discounts To Cover Both Harvoni And Viekira
This article was originally published in The Pink Sheet Daily
Executive Summary
Blue Cross Blue Shield-owned PBM Prime Therapeutics joins a growing list of payers announcing special reimbursement deals with Gilead and AbbVie as the pricing wars between the new hepatitis C drugs continue to unfold.